Merck & Co Inc (MRK)
99.13
-0.73
(-0.73%)
USD |
NYSE |
Nov 22, 16:00
99.21
+0.08
(+0.08%)
After-Hours: 18:00
Merck Free Cash Flow: 14.84B for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | 14.84B |
| June 30, 2024 | 13.15B |
| March 31, 2024 | 11.04B |
| December 31, 2023 | 9.143B |
| September 30, 2023 | 13.17B |
| June 30, 2023 | 10.83B |
| March 31, 2023 | 11.26B |
| December 31, 2022 | 14.71B |
| September 30, 2022 | 15.25B |
| June 30, 2022 | 14.40B |
| March 31, 2022 | 12.73B |
| December 31, 2021 | 9.661B |
| September 30, 2021 | 8.413B |
| June 30, 2021 | 5.516B |
| March 31, 2021 | 6.812B |
| December 31, 2020 | 5.824B |
| September 30, 2020 | 7.01B |
| June 30, 2020 | 9.549B |
| March 31, 2020 | 9.051B |
| December 31, 2019 | 10.07B |
| September 30, 2019 | 8.973B |
| June 30, 2019 | 7.846B |
| March 31, 2019 | 8.343B |
| December 31, 2018 | 8.307B |
| September 30, 2018 | 8.948B |
| Date | Value |
|---|---|
| June 30, 2018 | 5.196B |
| March 31, 2018 | 5.321B |
| December 31, 2017 | 4.563B |
| September 30, 2017 | 4.34B |
| June 30, 2017 | 8.514B |
| March 31, 2017 | 6.815B |
| December 31, 2016 | 8.762B |
| September 30, 2016 | 9.434B |
| June 30, 2016 | 9.867B |
| March 31, 2016 | 11.07B |
| December 31, 2015 | 11.26B |
| September 30, 2015 | 4.977B |
| June 30, 2015 | 6.01B |
| March 31, 2015 | 5.597B |
| December 31, 2014 | 5.672B |
| September 30, 2014 | 10.79B |
| June 30, 2014 | 10.36B |
| March 31, 2014 | 10.27B |
| December 31, 2013 | 10.11B |
| September 30, 2013 | 8.54B |
| June 30, 2013 | 7.671B |
| March 31, 2013 | 8.235B |
| December 31, 2012 | 8.068B |
| September 30, 2012 | 9.667B |
| June 30, 2012 | 11.09B |
Free Cash Flow Range, Past 5 Years
5.516B
Minimum
Jun 2021
15.25B
Maximum
Sep 2022
10.62B
Average
10.45B
Median
Free Cash Flow Benchmarks
| Amgen Inc | 6.283B |
| Johnson & Johnson | 19.02B |
| Eli Lilly and Co | -2.275B |
| Pfizer Inc | 8.227B |
| Moderna Inc | -3.956B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 9.291B |
| Cash from Investing (Quarterly) | -3.845B |
| Cash from Financing (Quarterly) | -2.425B |
| Free Cash Flow Per Share (Quarterly) | 3.348 |
| Free Cash Flow to Equity (Quarterly) | 8.165B |
| Free Cash Flow to Firm (Quarterly) | 8.665B |
| Free Cash Flow Yield | 5.89% |